Determinants of Photodynamic Therapy Resistance in Cancer Cells
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252212069 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Alicja Dąbrowska und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Wroclaw Medical University, Pasteura 1, 50-367 Wroclaw, Poland. Hauptthemen laut MEDLINE: Photochemotherapy, Neoplasms, Drug Resistance, Neoplasm, Photosensitizing Agents. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Molecular and Cellular Biology of Wroclaw Medical University.
Abstract (Originalsprache)
Photodynamic therapy (PDT) has emerged as a promising therapeutic approach owing to its non-invasive nature and minimal toxicity. PDT involves the administration of a photosensitizing agent (PS), which, upon light activation, induces a photodynamic reaction (PDR), leading to targeted cell destruction. However, developing resistance to PDT poses a significant challenge to its effectiveness. Various factors, including properties and administration of PSs, mediate this resistance. Despite the widespread use of substances like 5-aminolevulinic acid (5-ALA) and protoporphyrin, their efficacy is limited due to restricted tumor penetration and a lack of tumor targeting. To address these limitations, nano-delivery techniques and newer PSs like Aza-BODIPY and its derivatives, which offer enhanced tissue penetration, are being explored. In this paper, we provide an overview of resistance mechanisms in PDT and discuss novel methods, substances, and technologies to overcome resistance to improve clinical outcomes in tumor treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Wroclaw Medical University, Pasteura 1, 50-367 Wroclaw, Poland.
- Department of Clinical and Experimental Pathology, Wroclaw Medical University, T. Marcinkowskiego 1, 50-368 Wroclaw, Poland.
- Department of Molecular and Cellular Biology, Wroclaw Medical University, Borowska 211A, 50-556 Wroclaw, Poland.
ORCID-Profile: Alicja Dąbrowska, Jakub Mastalerz, Bartosz Wilczyński, Anna Choromańska
Förderung
- Department of Molecular and Cellular Biology of Wroclaw Medical University
Zitieren
APA
Dąbrowska, A., Mastalerz, J., Wilczyński, B., Osiecka, B., & Choromańska, A. (2024). Determinants of Photodynamic Therapy Resistance in Cancer Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252212069
Vancouver
Dąbrowska A, Mastalerz J, Wilczyński B, Osiecka B, Choromańska A. Determinants of Photodynamic Therapy Resistance in Cancer Cells. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252212069
BibTeX
@article{Dbrowska2024,
author = {Dąbrowska, Alicja and Mastalerz, Jakub and Wilczyński, Bartosz and Osiecka, Beata and Choromańska, Anna},
title = {Determinants of Photodynamic Therapy Resistance in Cancer Cells},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252212069}
}
EUVIMED